• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of anti-parkinsonism agent related to endogenous amines as pharmacophore

Research Project

Project/Area Number 03557094
Research Category

Grant-in-Aid for Developmental Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Chemical pharmacy
Research InstitutionUniversity of Tokyo

Principal Investigator

HIROBE Masaaki  University of Tokyo Faculty of Pharmaceutical Sciences, Professor, 薬学部, 教授 (20012594)

Co-Investigator(Kenkyū-buntansha) IWASAWA Yoshiro  Tanabe Pharmaceutical Co., Biological Research Center, 所長
HIGUCHI Tsunehiko  Faculty of Pharmaceutical Sciences, Assistant Professor, 薬学部, 助手 (50173159)
MASHINO Tadahiko  Faculty of Pharmaceutical Sciences, Assistant Professor, 薬学部, 助手 (90165697)
OHTA Shigeru  Faculty of Medicine, Associate Professor, 医学部, 助教授 (60160503)
Project Period (FY) 1991 – 1993
Project Status Completed (Fiscal Year 1993)
Budget Amount *help
¥9,800,000 (Direct Cost: ¥9,800,000)
Fiscal Year 1993: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1992: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1991: ¥7,700,000 (Direct Cost: ¥7,700,000)
KeywordsParkinson's Disease / Anti-parkinsonism agent / Tetrahydroisoquinoline derivatives / パ-キンソン病 / 抗パ-キンソン病薬
Research Abstract

It has been known for about 5 years that tetrahydroisoquinoline(TIQ) derivatives may be related to the onset of parkinsonism. TIQ and 1-methyi-1, 2, 3, 4- tetrahydroisoquinoline (1MeTIQ) are endogenous amines coexisting in the brain of many species including humans. Mareover, 1MeTIQ has a preventive effect against parkinsonism in mice.
Methyl derivative of TIQs were synthesized in preparative scale. And these pharmacological effects were investigated. From the structure-activity relationship, a methyl group attached 1 position is contributed to locomotive activity. The number of methyl groups is affected toxicity. These findings will be useful for further investigation to find out anti-parkinsonism agents.
On the way of the investigation, we found that 1-benzyl-TIQ (1BnTIQ) had very strong neurotoxic character. This compound was also an endogeneous amine in human brain. The content of 1-BnTIQ in parkinsonians is higher than control subjects. So from these data, 1BnTIQ is a very suitable candidate for parkinsonism causing substance.

Report

(4 results)
  • 1993 Annual Research Report   Final Research Report Summary
  • 1992 Annual Research Report
  • 1991 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] H.Nakagawa: "A novel metabolite of 3,4-methylenedioxyamphetamine(MDA):formation of 3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline and its pharmacological" Biol.Pharm.Bull.16. 579-582 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] M.Tateyama: "Effect of 4-Phenyl-1,2,3,4-tetrahydroisoquinoline on ambulation induced by injection of methamphetamine into the nucleus accumbens in rats." Neuropharmacology. 32. 243-248 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] M.Tateyama: "Inhibitory effect of 4-Phenyltetrahydroisoquinoline on locomotion and dopamine release induced by micro-injection of methamphetamine into…" Neuropharmacology. 32. 761-766 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] M.Tateyama: "4-Phenyltetrahydroisoquinoline,but not homifensine or cocaine,inhibits methamptetamine-induced dopamine release." Eur.J.Pharmacol.240. 51-56 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] H.Watanabe: "Methamptetamine antagonistic property of(+)-and(-)-4-Phenyltetrahydroisoquinoline in rat and coccygeus muscle." Eur.J.Pharmacol.243. 155-161 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] H.Nakagawa, Y.Makino, Y.Yoshida, S.Ohta, M.Hirobe.: "A novel metabolite of 3, 4-methylenedioxyamphetamine (MDA) : formation of 3-methyl-6, 7-methylenedioxy-1, 2, 3, 4-tetrahydroisoquinoline and its pharmacological effect." Biol.Pharm.Bull.16. 579-582 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] M.Tateyama, S.Ohta, T.Nagao, M.Hirobe, H.Ono.: "Effect of 4-phenyl-1, 2, 3, 4-tetrahydroisoquinoline on ambulation induced by injection of methamphetamine into the nucleus accumbens in rats." Neuropharmacology. 32. 243-248 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] M.Tateyama, S.Ohta, T.Nagao, M.Hirobe, H.Ono.: "Inhibitory effect of 4-phenyltetrahydroisoquinoline on loco-motion and dopamine release induced by micro-injection of methamphetamine into the nucleus accumbens of the rat." Neuropharmacology. 32. 761-766 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] M.Tateyama, T.Nagao, S.Ohta, M.Hirobe, H.Ono.: "4-Phenyltetrahydroisoquinoline, but not nomifensine or cocaine, inhibits methamphetamine-induced dopamine release." Eur.J.Pharmacol. 240. 51-56 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] H.Watanabe, M.Tateyama, T.Nagao, S.Ohta, M.Hirobe.: "Methamphetamine antagonistic property of (+)-and(-)-4-phenyltetrahydroisoquinoline in rat anococcygeus muscle." Eur.J.Pharmacol.243. 155-161 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] H.Nakagawa: "A novel metabolite of 3,4-methylenedioxyamphetamine(MDA):formation of 3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinotine and its pharmacologial" Biol.Pharm.Bull.16. 579-582 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] M.Tateyama: "Effect of 4-Phenyl-1,2,3,4-tetrahydroisoquinoline on ambulation induced by injection of methamphetamine into the nudeus accumbeus in rats" Neuropharmacology. 32. 243-248 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] M.Tateyama: "Inhibitory effect of 4-Phenyl tetragydroisoquenoline on locomotion and dopamine release induced by micro-inyection of methamphetamine into…" Neuropharmacology. 32. 761-766 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] M.Tateyama: "4-phenyl tetrahydroisoquinoline,but not nomifensine or cocaine,inhibits methamptetamine-induced dopamine release." Eur.J.Pharmacol.240. 51-56 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] H.Watanabe: "Methamptetamine antagonistic property of(+)-and(-)-4-phenyl tetra-hydroisoquinoline in rat anococcygeus muscle." Eur.J.Pharmacol. 243. 155-161 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] T.Suzuki: "Cytochrome P-450 isozymes catalyzing 4-hydroxylation of parkinsonism related compaund,1,2,3,4-tetrahychroisoguimline" FASEB.J.6. 771-776 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] M.Satoh: "Amphetamine-antagonistic property of 4-phemyltetrahydroisoguindine effect on noradrenaline relase in spncal cord slices" Japan J.Pharmacol.60. 121-125 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] W.Maruyama: "Selective release of serotonin by endogenus alkaloids 1-metyl-6,7-dihyoroxy-1,2,3,4-tetrolydroisoguirolines.(R)-and-(S)salsolinol,in the rat stuiatum:in vivo microdiahysis study" Neurosci,Letl. 149. 115-118 (1993)

    • Related Report
      1992 Annual Research Report
  • [Publications] H.Nakagawa: "A novel metabolite of 3,4-mettaylene dioxy amphetamine(MDA)formation of 3-methyl-6,7-metuylenedioxy-1,2,3,4-tetrahydn isoguinoline and its pharunacologycal effect" Biological.Pharum.Bull. (1993)

    • Related Report
      1992 Annual Research Report
  • [Publications] Y.Tasaki: "Parkinson's disease:from basic research to treatment" Raven Press, 4 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Y.Tasaki: "1-Methy L-1,2,3,4-tetrahydroisoguinolive(1MeTIQ),decreasing in MPTP-treated mouse,prevents parkinsonism-Like behavior abnormalities" J.Neurochem.57. 1940-1943 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] H.Ono: "Amphetamine-antagonistic property of 4-phenyl-1,2,3,4-tetrahydroisoguinoline:inhibition of spinal reflex-enhancing effects of methamphetamine,phenylethylamine and nomifensine" Brain Research.564. 319-322 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] K.Kikuchi: "Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds:1,2,3,4-tetrahydroisoguinoline (TIQ)and 1-methyl-1,2,3,4-tetrahydroisoguinoline(1MeTIQ)." Drug.Metab.Dispos.19. 257-262 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] T.Suzuki: "Cytochrome P-450 isozymes catalysing 4-hyclroxylation of parkinsonism related compound,1,2,3,4-tetrahydroisoguindine in rat liver microsomes" FASEB J.6. 771-776 (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] S.Ohta: "Basic,clinical and therapeutic of Alzheimer's and Parkinson's diseases" Plenum press., 4 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] S.Ohta: "Parkinson's disease,From clinical aspects to Molecular basis" Springer Verlag, 7 (1991)

    • Related Report
      1991 Annual Research Report

URL: 

Published: 1991-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi